Navigation Links
Antipsychotic Iloperidone Results Show Favorable Akathisia Profile

h a dual serotonin and dopamine receptor antagonist profile. Clinical trial experience with iloperidone suggests that this balanced antagonism may provide efficacy against positive and negative symptoms of schizophrenia, while causing reduced EPS and hyperprolactinemia relative to other available atypical antipsychotics. Iloperidone also appears to have a favorable weight and metabolic profile. In addition, Vanda is developing a genetic blood test to help identify those patients most likely to benefit from iloperidone.

Vanda has completed its Phase III program for iloperidone in schizophrenia and expects to file a new drug application (NDA) for the oral formulation in Q4 2007. Vanda is also developing a four-week injectable formulation of the compound.

About Schizophrenia

Schizophrenia is a chronic, severe and disabling brain disorder that affects approximately one percent of Americans. Patients suffering from schizophrenia exhibit a range of symptoms, which are classified into three broad categories:

    -- Positive symptoms reflect an excess or distortion of normal functions

       (e.g., hallucinations, delusions, thought and movement disorders).

    -- Negative symptoms represent a loss or decrease in the ability to

       initiate plans, speak, express emotion, or find pleasure in everyday

       life.

    -- Cognitive symptoms include problems with attention, memory or planning,

       and often interfere with normal routines.

Unmet Needs in Schizophrenia

Although there are many drugs approved to treat schizophrenia, including the commonly prescribed "atypical antipsychotics," a high degree of dissatisfaction remains among physicians and patients. The recent CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) study, conducted by the National Institute of Mental Health and reported in The New England Journal of Medicine, evaluated several antipsychotic medications and revealed that 74% of pa
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. New Data Show Early Non-Response to Antipsychotic Treatment May Be Strong Predictor of Subsequent Non-Response for People with Schizophrenia
2. Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007 American Psychiatric Association Annual Meeting
3. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
4. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
5. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
6. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
7. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:9/17/2014)... 2014  Decision Resources Group finds that ... for biologic therapy, only a proportion of ... cite patients, discomfort with biological therapy as ... followed by cost-related issues and payer restrictions. ... Janssen Biotech,s Remicade and AbbVie,s Humira are ...
(Date:9/17/2014)... and SAN JOSE, Calif. , ... has been named as a laureate of The Tech Awards ... applying technology to benefit humanity and spark global change. The ... Innovation, and presented by Applied Materials, Inc., selected Gradian as ... Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
(Date:9/17/2014)... , Sept. 17, 2014  Lightbeam Health Solutions ... Care Organization (Physician Direct ACO) to deploy the ... in providing better care while reducing costs. ... Physician Direct Accountable Care Organization is the ... (OPNS). The OPNS mission is to be the ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3
... Oct. 13 Allscripts (Nasdaq: ... financial results for the three and nine months ended ... on Monday, November 8, 2010. Allscripts management will host ... earnings and other information at 4:30 PM Eastern Standard ...
... (Nasdaq: STXS ) announced today that the new ... of 2010.  The Company generated new capital orders of $12.2 ... placed during the third quarter of 2009, and a 19% ... the Company,s Niobe® Remote Magnetic Navigation System totaled $8.1 million, ...
Cached Medicine Technology:Allscripts to Announce Third Quarter 2010 Results on November 8, 2010 2Allscripts to Announce Third Quarter 2010 Results on November 8, 2010 3Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year 2Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year 3Stereotaxis Announces Third Quarter 2010 Capital Orders of $12.2 Million, Up 94 Percent Year-to-Year 4
(Date:9/17/2014)... 2014 People who struggle to distinguish between ... http://www.perwickstrom.com and get the answer by reading Per ... out, is that a business plan and a business strategy ... commented Per Wickstrom. “The way I view it is that ... strategy which is part two.” , According to the ...
(Date:9/17/2014)... damage to the ends of chromosomes could hold the key ... form of skin cancer according to new research from ... an important new genetic risk factor for melanoma. , It ... strongest indicators of those most at risk of developing melanoma. ... sun, as they burn more easily. , It now appears ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 North Central ... recently granted several awards for their top-notch services. The ... experience, orthopedic care and GYN surgery. , Hospital-wide, North ... Excellence Award™. They have received this award for two ... the top 5 percent in the nation for Patient ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Tidewater ... host recruit757’s scholarship workshop for football players and their ... Sept. 23. , Doors open at 6:30 p.m. for ... and speak to trainers and physical therapists. The workshop ... p.m. , The Newport News Tidewater Performance Center, which ...
(Date:9/17/2014)... News) -- Positive messages about the health benefits of ... a new study suggests. Although smokers who think ... about the harmful effects of smoking, researchers found smokers ... more from "gain-framed," or positive, messages about how quitting ... using a mix of both types of messages might ...
Breaking Medicine News(10 mins):Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:Chromosome buffers hold key to better melanoma understanding 2Health News:North Central Surgical Center Receives Several Accolades 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 2Health News:Tidewater Physical Therapy and Performance Services and recruit757 To Host Football Scholarship Seminar 3Health News:More Than One Kind of Message May Convince Smokers to Quit, Study Says 2
... Washingtonian ... ... was identified as a "Top Therapist" in the July 2009 issue of Washingtonian ... playing in the Washington, DC, area for more than four decades thanks to features like ...
... ... supplier of industrial and technical parts and free CAD images to engineers, ... customers. John Carrier, the company,s President, says the new ReidSupply.com is all about ... on marketing. The new site takes the customer exactly where they want to ...
... LONDON, July 7 Frost & Sullivan has conferred ... (VWS). The "2008 Frost & Sullivan European Pharmaceutical Water ... VWS for its successful strategies that have enabled it ... process water and wastewater solution providers for the pharmaceutical ...
... OAK BROOK, Ill. (July 7, 2009) Using magnetic resonance ... and accurately locate lesions prior to surgery, according to a ... . "Pelvic MRI at 3 Tesla is a ... said the study,s lead author, Nathalie Hottat, M.D., from the ...
... SMOKING CESSATION MAY PROVIDE IMMEDIATE BENEFIT TO HEART ... provides immediate benefits to patients. Researchers from the ... examined specific inflammatory biomarkers associated with cardiovascular disease ... cessation process. Results showed that smoking cessation resulted ...
... Sonitus Medical, Inc., a medical device company developing the ... sound via the teeth, today announced the acceptance for ... SoundBite(TM) hearing system. The article, featuring a preliminary evaluation ... in an upcoming issue of the esteemed Otology ...
Cached Medicine News:Health News:Karen J. Osterle Recognized as a Top Psychotherapist in Washingtonian Magazine 2Health News:Customers Design Reid Supply's New Web Site 2Health News:Customers Design Reid Supply's New Web Site 3Health News:Customers Design Reid Supply's New Web Site 4Health News:Customers Design Reid Supply's New Web Site 5Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 2Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 3Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 4Health News:Dual Frost & Sullivan Accolade for Veolia Water Solutions & Technologies 5Health News:MRI accurately depicts deep endometriosis 2Health News:News briefs from the July issue of CHEST 2Health News:SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal 2Health News:SoundBite(TM) Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology & Neurotology Journal 3
ENDOlap™ laparoscopes provide excellent image linearity and flatness of field....
Inquire...
The Fujinon's R410 laparoscope is the first to bring a 410,000 pixel CCD to the end of the scope. Superior imaging and color replication, along with a unique lens washing capability make the R410 the...
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: